Zoetis (ZTS) Operating Expenses (2012 - 2026)
Zoetis' (ZTS) quarterly Operating Expenses came in at $215.0 million in Q2 2026, down 1.38% year-over-year from $218.0 million in Q2 2025, and up 8.04% quarter-over-quarter from $199.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Operating Expenses (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Operating Expenses for 15 consecutive years, with $215.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Expenses fell 1.38% year-over-year to $215.0 million in Q2 2026; TTM through Jun 2026 was $808.0 million, a 3.12% decrease from a year earlier, with the FY2025 full-year figure at $817.0 million, up 1.49% from the prior year.
- Operating Expenses was $215.0 million for Q2 2026 at Zoetis, up from $199.0 million in the prior quarter.
- Over five years, Operating Expenses peaked at $218.0 million in Q2 2025 and troughed at $165.0 million in Q1 2022.
- A 5-year average of $199.3 million and a median of $201.5 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses grew 25.95% in 2022 and dropped 8.96% in 2025, its largest moves.
- Over 5 years, Operating Expenses stood at $187.0 million in 2022, then slipped by 1.6% to $184.0 million in 2023, then increased by 15.22% to $212.0 million in 2024, then dropped by 8.96% to $193.0 million in 2025, then rose by 11.4% to $215.0 million in 2026.
- The last three Operating Expenses figures came in at $215.0 million (Q2 2026), $199.0 million (Q1 2026), and $193.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.55 Bn | 40.36 Bn | 779.09 Mn | 353.52 Mn |
| 2 | Zoetis | 30.68 Bn | 29.00 Bn | 1.05 Bn | 215.00 Mn |
| 3 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 550.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 94.31 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 502,288.00 |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 292,311.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 215.00 Mn |
| Mar 31, 2026 | 199.00 Mn |
| Dec 31, 2025 | 193.00 Mn |
| Sep 30, 2025 | 201.00 Mn |
| Jun 30, 2025 | 218.00 Mn |
| Mar 31, 2025 | 205.00 Mn |
| Dec 31, 2024 | 212.00 Mn |
| Sep 30, 2024 | 199.00 Mn |
| Jun 30, 2024 | 204.00 Mn |
| Mar 31, 2024 | 190.00 Mn |
| Dec 31, 2023 | 184.00 Mn |
| Sep 30, 2023 | 202.00 Mn |
| Jun 30, 2023 | 212.00 Mn |
| Mar 31, 2023 | 188.00 Mn |
| Dec 31, 2022 | 187.00 Mn |
| Sep 30, 2022 | 206.00 Mn |
| Jun 30, 2022 | 207.00 Mn |
| Mar 31, 2022 | 165.00 Mn |
| Dec 31, 2021 | 197.00 Mn |
| Sep 30, 2021 | 183.00 Mn |